Literature DB >> 6997121

Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution.

R Ebert, W Creutzfeldt.   

Abstract

The influence of impaired digestion on nutrient induced release of gastric inhibitory polypeptide (GIP) and insulin have been investigated in patients with chronic pancreatitis. All patients had massive steatorrhea (> 25 g/24 h), and glucose intolerance. A standard liquid test meal comprising fat and glucose were ingested with or without pancreatic enzyme substitution (9.0 g pancreatin). In the presence of pancreatin the response of serum levels of GIP to the test meal was significantly enhanced (81.2 vs 194.5 microgram/l X 180 min). Concurrently, the insulin response was augmented (3.4 vs 6.4 U/l X 180 min), resulting in improved glucose tolerance. Addition of pancreatin also significantly augmented the GIP response to oral fat (100 g), but not to oral glucose (100 g). In patients with pancreatogenic steatorrhea the insulin response to an IV glucose infusion (0.7 g/kg/h for 90 min) was augmented by oral fat only after addition of 9.0 g pancreatin to the fat load (3.5 vs 7.3 U/l X 180 min). After restoration of the GIP response to fat by pancreatin, the inhibitory effect of IV glucose on fat-induced GIP increase was restored. These data indicate that the GIP response to a mixed meal or triglycerides is dependent on the absorption of nutrients. In patients with chronic pancreatitis improvement of pancreatogenic insufficiency reverses the impaired GIP response, restores the incretin effect of fat, and improves glucose tolerance.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6997121     DOI: 10.1007/bf00275269

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

Review 1.  Identification and actions of gastric inhibitory polypeptide.

Authors:  J C Brown; J R Dryburgh; S A Ross; J Dupré
Journal:  Recent Prog Horm Res       Date:  1975

2.  The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects.

Authors:  S E Crockett; S Cataland; J M Falko; E L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  1976-06       Impact factor: 5.958

Review 3.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

4.  Stimulation of insulin secretion by gastric inhibitory polypeptide in man.

Authors:  J Dupre; S A Ross; D Watson; J C Brown
Journal:  J Clin Endocrinol Metab       Date:  1973-11       Impact factor: 5.958

5.  The effect of oral galactose on GIP and insulin secretion in man.

Authors:  L M Morgan; J W Wright; V Marks
Journal:  Diabetologia       Date:  1979-04       Impact factor: 10.122

6.  Response of gastric inhibitory polypeptide (GIP) to test meal in chronic pancreatitis--relationship to endocrine and exocrine insufficiency.

Authors:  R Ebert; W Creutzfeldt; J C Brown; H Frerichs; R Arnold
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

7.  Impaired pancreatic polypeptide release in chronic pancreatitis with steatorrhoea.

Authors:  T E Adrian; H S Besterman; C N Mallinson; C Garalotis; S R Bloom
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

8.  Release of motilin by oral and intravenous nutrients in man.

Authors:  N D Christofides; S R Bloom; H S Besterman; T E Adrian; M A Ghatei
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

9.  Duodenal endocrine cells in adult coeliac disease.

Authors:  K Sjölund; J Alumets; N O Berg; R Håkanson; F Sundler
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

10.  Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man.

Authors:  S Cataland; S E Crockett; J C Brown; E L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

View more
  28 in total

1.  Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012.

Authors:  Michael R Rickels; Melena Bellin; Frederico G S Toledo; R Paul Robertson; Dana K Andersen; Suresh T Chari; Randall Brand; Luca Frulloni; Michelle A Anderson; David C Whitcomb
Journal:  Pancreatology       Date:  2013-05-17       Impact factor: 3.996

Review 2.  [Exocrine pancreatic insufficiency and diabetes mellitus].

Authors:  Raimund Weitgasser; Heidemarie Abrahamian; Martin Clodi; Sandra Zlamal-Fortunat; Heinz F Hammer
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

Review 3.  Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.

Authors:  Phil A Hart; Melena D Bellin; Dana K Andersen; David Bradley; Zobeida Cruz-Monserrate; Christopher E Forsmark; Mark O Goodarzi; Aida Habtezion; Murray Korc; Yogish C Kudva; Stephen J Pandol; Dhiraj Yadav; Suresh T Chari
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-10-12

4.  Recurrent diabetic ketoacidosis: a rare presenting manifestation of primary hyperparathyroidism.

Authors:  Rajesh Rajput; Ashima Mittal; Jasminder Singh; Satish Dalal; Shaweta Vohra
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10

Review 5.  The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis.

Authors:  S N Duggan; N Ewald; L Kelleher; O Griffin; J Gibney; K C Conlon
Journal:  Eur J Clin Nutr       Date:  2016-07-13       Impact factor: 4.016

6.  Determinants of glucose control in patients with chronic pancreatitis.

Authors:  H Schrader; B A Menge; C Zeidler; P R Ritter; A Tannapfel; W Uhl; W E Schmidt; J J Meier
Journal:  Diabetologia       Date:  2010-03-09       Impact factor: 10.122

Review 7.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

8.  [Position paper: Exocrine pancreatic insufficiency and diabetes mellitus].

Authors:  Raimund Weitgasser; Heidemarie Abrahamian; Martin Clodi; Werner Fortunat; Heinz Hammer
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

9.  Nutrient-driven incretin secretion into intestinal lymph is different between diabetic Goto-Kakizaki rats and Wistar rats.

Authors:  Tammy L Kindel; Qing Yang; Stephanie M Yoder; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-04       Impact factor: 4.052

10.  Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

Authors:  Devi Mukkai Krishnamurty; Atoosa Rabiee; Sanjay B Jagannath; Dana K Andersen
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.